Recent News

• 05.28.2025 - PepGen to Focus on Development of Promising DM1 Program Following 10 mg/kg PGN-EDO51 Update
• 05.28.2025 - PepGen to Focus on Development of Promising DM1 Program Following 10 mg/kg PGN-EDO51 Update
• 05.20.2025 - PepGen Appoints Kasra Kasraian, PhD, as Chief Technology Officer
• 05.20.2025 - PepGen Appoints Kasra Kasraian, PhD, as Chief Technology Officer
• 05.08.2025 - PepGen Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
• 05.08.2025 - PepGen Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
• 04.09.2025 - 24th Annual Needham Virtual Healthcare Conference
• 04.09.2025 - 24th Annual Needham Virtual Healthcare Conference

Recent Filings

• 05.21.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.21.2025 - 3 Initial statement of beneficial ownership of securities
• 05.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.08.2025 - EX-99.1 EX-99.1
• 05.08.2025 - 8-K Current report
• 05.08.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 04.25.2025 - DEF 14A Other definitive proxy statements
• 04.25.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.25.2025 - ARS Annual Report to Security Holders